Article
Acella recalls some levothyroxine tablets due to subpotency
Rating:
0.0
Views:
66
Likes:
1
Library:
1
Acella Pharmaceuticals is voluntarily recalling one lot of 15 mg and one lot of 120 mg levothyroxine and liothyronine tablets due to subpotency, according to an FDA announcement.The levothyroxine and liothyronine tablets (NP Thyroid) are being recalled because testing has found they may have as low as 87% of the labeled amount of levothyroxine, according to the agency announcement.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value